113617-63-3 Orbifloxacin
| 상품명칭 |
Orbifloxacin |
| 영문 이름 |
Orbifloxacin; 1-Cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 3-quinolinecarboxylic acid, 1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-1,4-dihydro-4-oxo- |
| 분자식 |
C19H20F3N3O3 |
| 분자량 |
395.3756 |
| InChI |
InChI=1/C19H20F3N3O3/c1-8-5-24(6-9(2)23-8)17-14(21)13(20)12-16(15(17)22)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6H2,1-2H3,(H,27,28)/t8-,9+ |
| cas번호 |
113617-63-3 |
| 분자 구조 |
|
| 밀도 |
1.436g/cm3 |
| 비등점 |
590.7°C at 760 mmHg |
| 굴절 지수 |
1.588 |
| 인화점 |
311.1°C |
| 증기압 |
8.43E-15mmHg at 25°C |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
KR
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
MY
NL
NO
PL
PT
RU
SA
TR
